ロード中...
Graft-versus-Host Disease Biomarkers: Omics and Personalized Medicine
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective form of tumor immunotherapy available to date and the frequency of transplants continues to increase worldwide. However, while allo-HSCT usually induces a beneficial graft-versus-leukemia (GVL) effect, a major sourc...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4005044/ https://ncbi.nlm.nih.gov/pubmed/23959582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-013-1406-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|